In the ovarian cancer survival prediction, our methodology identified Epidermal Growth Factor receptor signaling pathway and the Activation of AKT as the top pathways known for their association to ovarian cancer (Smolle et al. 2013) (refer to Supplementary Fig. S7). This evidence concerns the gene EGFR and ovarian carcinoma.